2005 Dec;30(12):1493-500
What exists instead is extrapolated evidence from other rapid weight loss contexts
supports insulin sensitivity Nervous System: Protects against neurodegeneration and cognitive decline Skin: Improves autoimmune conditions and accelerates wound healing Future Applications of GLP-1 Medications As clinical trials continue, GLP-1 receptor agonists may soon be approved for: Neurodegenerative diseases: Alzheimers, Parkinsons, MS Autoimmune conditions: Psoriasis, RA, Lupus Cardiometabolic syndromes: NAFLD, PCOS, atherosclerosis Pulmonary conditions: Chronic bronchitis, COPD, even long-COVID inflammation Final Thoughts GLP-1 medications are no longer just diabetes or weight loss drugs
Most patients find it nearly painless
Enhances skin clarity and brightness Provides essential nutrients for skin repair and cell regeneration
Semaglutide is administered once weekly via subcutaneous injection, and the thigh is one of three approved injection sites alongside the abdomen and upper arm